Dec 19, 2014

The immunology of asthma

Nature Immunology
Bart N Lambrecht, Hamida Hammad


Asthma is a common disease that affects 300 million people worldwide. Given the large number of eosinophils in the airways of people with mild asthma, and verified by data from murine models, asthma was long considered the hallmark T helper type 2 (TH2) disease of the airways. It is now known that some asthmatic inflammation is neutrophilic, controlled by the TH17 subset of helper T cells, and that some eosinophilic inflammation is controlled by type 2 innate lymphoid cells (ILC2 cells) acting together with basophils. Here we discuss results from in-depth molecular studies of mouse models in light of the results from the first clinical trials targeting key cytokines in humans and describe the extraordinary heterogeneity of asthma.

  • References177
  • Citations452


  • References177
  • Citations452


Mentioned in this Paper

SpecimenType - Basophils
Lymphoid Cells
Eosinophils as Percentage of Blood Leukocytes
Specimen Type - Eosinophils

Related Feeds


This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.


Basophils are myeloid cells with a high affinity IgE receptor and is involved in inflammatory responses during allergy. Discover the latest research on Basophils here.

Related Papers

Current Opinion in Allergy and Clinical Immunology
Sejal Saglani, Clare M Lloyd
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Mamoru TasakiYoshitaka Hirayama
Trends in Immunology
Julie DeckersHamida Hammad
© 2020 Meta ULC. All rights reserved